1. Fast Facts: Multiple Myeloma and Plasma Cell Dyscrasias;K Ramasamy,2015
2. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back;G Bianchi;CA Cancer J Clin,2014
3. Cancer Research UK. Myeloma Statistics. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/myeloma#heading-Six (Accessed: 30 November 2018)
4. National Institute for Care and Clinical Excellence. Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation. Available from: https://www.nice.org.uk/guidance/ta311 (Accessed 24th January 2018)
5. National Institute for Care and Clinical Excellence. Bortezomib and thalidomide for the first‑line treatment of multiple myeloma. Available from: https://www.nice.org.uk/Guidance/ta228 (Accessed 24th January 2018)